Cartilage and bone repair and regeneration using postpartum-derived cells
US11191789B2 · kind B2 · utility
0Cited by
111References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 25, 2004 |
| Grant date | Dec 7, 2021 |
| Priority date | — |
| Expiry date | Nov 21, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2533/50
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Cells derived from postpartum tissue and methods for their isolation and induction to differentiate to cells of a chondrogenic or osteogenic phenotype are provided by the invention. The invention further provides cultures and compositions of the postpartum-derived cells and products related thereto. The postpartum-derived cells of the invention and products related thereto have a plethora of uses, including but not limited to research, diagnostic, and therapeutic applications, for example, in the treatment of bone and cartilage conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.